Trial ID
20341
Sponsor ID
BESPOKE
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (20-041-NCP)
Principal Investigator
Keeran R. Sampat, MD
3 Locations
Locations
Arlington Office
Fairfax Office
Gainesville Office
Learn More About This Trial
Other Relevant Trials
Trial ID
C-800-25
Sponsor ID
Agenus
“A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY OF BOTENSILIMAB (AGEN1181) AS MONOTHERAPY AND IN COMBINATION WITH BALSTILIMAB (AGEN2034) FOR THE TREATMENT OF ADVANCED, REFRACTORY MICROSATELLITE STABLE COLORECTAL CANCER WITHOUT LIVER METASTASES”
Principal Investigator
Chao Yin, MD
2 Locations
Trial ID
21386
Sponsor ID
BNT122-01
“A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection (BNT122-01)”
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
